Fingerprint
Dive into the research topics of 'Phase I study of single-agent AZD1775 (MK-1775), a wee1 kinase inhibitor, in patients with refractory solid tumors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I study of single-agent AZD1775 (MK-1775), a wee1 kinase inhibitor, in patients with refractory solid tumors
Khanh Do, Deborah Wilsker, Jiuping Ji, Jennifer Zlott, Tomoko Freshwater, Robert J. Kinders, Jerry Collins, Alice P. Chen, James H. Doroshow, Shivaani Kummar
Research output: Contribution to journal › Article › peer-review
248
Scopus
citations